At a glance
ClinicalIndex Comparison RecordN/ACompleted· 700 enrolled
Drug / intervention
apixisabandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
In Brief
An observational study evaluating apixisaban for Ischemic Stroke. Completed, enrolled 700 participants across 1 site.
Detailed Summary
The aim of this study is to investigate the clinical events of the patients with acute cerebral large vessel occlusion or stenosis and atrial fibrillation, treated by apixaban within 14 days after onset. This is the observational study that patients will be made the registration at the timing of both retrospective period and prospective period.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJul 2016
Primary CompletionFeb 2018
TodayJul 2026
First PostedJun 30, 2016
Enrollment StartJul 1, 2016
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.0 years ago
Interventions
apixisabandrug